NuNaf Tablets (SODIUM FLUORIDE TABLETS B.P) Back
Composition:
Each enteric coated tablet contains
Sodium Fluoride I.P. 20 mg
Excipients q.s.
Indication:
Otosclerosis
Description:
- Nunaf is an enzyme inhibitor, reduces osteoclastic bone resorption and increases osteoblastic bone formation
- Stabilizes the hearing loss associate with otosclerosis
- Stops further progression of otosclerotic damage
- Reduces tinnitus and any other symptoms of imbalance associated with otosclerosis, it stops further progression of otosclerotic damage
- Used for 6-12 months prior to stapedectomy
Dosage:
As directed by physician
Presentation:
Blister strip of 10 tablets
Note: To be used only on the advice of a Registered Medical Practitioner.
